Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity have entered the fray to take over Orchid Pharma. Separately, Aurobindo Pharma has completed the acquisition of portfolio of seven marketed oncology injectable products from Spectrum while Motherson Rolling Stock Systems (MRSS) is acquiring Bombardier’s assets in connection with the production and installation of electrical components and systems.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in